Related Experiment Video
Updated: Jun 9, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study
Katarzyna Malgorzata Kwiatkowska1, Nicola Martinelli2, Luca Bertamini3,2,4
1Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126, Bologna, Italy. katarzyn.kwiatkowsk2@unibo.it.
Insights
Clonal hematopoiesis of indeterminate potential (CHIP) is linked to increased cardiovascular disease risk. Our study found higher somatic variant burdens in CAD patients, suggesting CHIP
Area of Science:
- Hematology
- Cardiovascular Disease
- Genetics
Background:
- Clonal hematopoiesis of indeterminate potential (CHIP) involves somatic mutations in hematopoietic stem cells.
- CHIP is associated with increased all-cause mortality, primarily from cardiovascular events.
- Understanding CHIP's role in cardiovascular aging is vital for improving health and lifespan.
Purpose of the Study:
- To investigate the association between clonal hematopoiesis and cardiovascular aging in the Verona Heart Study (VHS) cohort.
- To compare somatic variant burdens in individuals with coronary artery disease (CAD) versus healthy controls.
- To identify specific genes and genetic regions associated with CHIP in the context of CAD.
Main Methods:
- Deep sequencing and amplicon-based approaches were used to analyze 11 key genes (ASXL1, DNMT3A, IDH1, IDH2, JAK2, PPM1D, SF3B1, SRSF2, TET2, TP53, U2AF1).
- Samples from 44 CAD patients and 42 age- and sex-matched healthy controls (CAD-FREE) from the VHS cohort were analyzed.
- Variant burden, including total and disruptive somatic variants, was quantified and compared between groups.
Main Results:
- Subjects with CAD exhibited a significantly higher total somatic variant burden compared to the CAD-FREE group.
- Elevated variant rates in specific regions of ASXL1, DNMT3A, IDH2, JAK2, TET2, and U2AF1 were observed in CAD subjects.
- ASXL1, DNMT3A, IDH2, JAK2, SF3B1, TET2, and TP53 showed substantially higher levels of disruptive variants in the CAD group.
Conclusions:
- A correlation exists between clonal hematopoiesis and the accumulation of disruptive variants in specific genomic regions within the VHS cohort.
- These findings suggest a potential role for CHIP and associated genetic variants in the pathophysiology of cardiovascular aging.
- Further research into CHIP may provide insights into novel therapeutic targets for cardiovascular disease.
Abstract:
Clonal hematopoiesis of indeterminate potential (CHIP), marked by the accumulation of somatic mutations in hematopoietic stem cells, significantly elevates the risk of all-cause mortality, mainly due to cardiovascular events. Therefore, investigating this pathophysiological phenomenon is crucial for understanding cardiovascular aging and enhancing both health span and lifespan. In the present study, we examined samples of subjects enrolled within the angiographically controlled Verona Heart Study (VHS), which provides a robust model for cardiovascular aging, particularly regarding coronary artery disease (CAD). We analyzed 44 older subjects diagnosed with coronary artery disease (CAD) and 42 healthy, sex- and age-matched controls (CAD-FREE). Employing deep sequencing and an amplicon-based approach, we focused on 11 key genetic regions in ASXL1, DNMT3A, IDH1, IDH2, JAK2, PPM1D, SF3B1, SRSF2, TET2, TP53, and U2AF1 genes to investigate clonal hematopoiesis. Subjects in the CAD group exhibited a significantly higher variant burden than those in the CAD-FREE group, both in terms of the total number of somatic variants and disruptive variants affecting protein function. This increased mutational load was notably influenced by six specific genetic regions: ASXL1, DNMT3A, IDH2, JAK2, TET2, and U2AF1, which displayed elevated variant rates in the CAD subjects. Moreover, ASXL1, DNMT3A, IDH2, JAK2, SF3B1, TET2, and TP53 exhibited substantially higher levels of disruptive variants in the CAD group. In summary, our findings highlight a correlation between clonal hematopoiesis and the accumulation of disruptive variants in specific genomic regions in the VHS cohort, thereby shedding light on their potential role in cardiovascular aging.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hematopoiesis
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Heart Failure II: Pathophysiology
The Effect of Aging on Tissues
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

